GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » EV-to-EBIT

Medipost Co (Medipost Co) EV-to-EBIT : 107.57 (As of Jun. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medipost Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medipost Co's Enterprise Value is $636.72 Mil. Medipost Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $5.92 Mil. Therefore, Medipost Co's EV-to-EBIT for today is 107.57.

The historical rank and industry rank for Medipost Co's EV-to-EBIT or its related term are showing as below:

MEPTF' s EV-to-EBIT Range Over the Past 10 Years
Min: -21605.2   Med: 5.45   Max: 9533.84
Current: 11.28

During the past 13 years, the highest EV-to-EBIT of Medipost Co was 9533.84. The lowest was -21605.20. And the median was 5.45.

MEPTF's EV-to-EBIT is ranked worse than
53.86% of 427 companies
in the Biotechnology industry
Industry Median: 9.52 vs MEPTF: 11.28

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medipost Co's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil. Medipost Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $5.92 Mil. Medipost Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.


Medipost Co EV-to-EBIT Historical Data

The historical data trend for Medipost Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co EV-to-EBIT Chart

Medipost Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -164.43 -132.83 80.72 77.06 11.44

Medipost Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.54 5.62 11.29 12.26 13.28

Competitive Comparison of Medipost Co's EV-to-EBIT

For the Biotechnology subindustry, Medipost Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medipost Co's EV-to-EBIT falls into.



Medipost Co EV-to-EBIT Calculation

Medipost Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=636.716/5.919
=107.57

Medipost Co's current Enterprise Value is $636.72 Mil.
Medipost Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipost Co  (OTCPK:MEPTF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medipost Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=5.919/0
= %

Medipost Co's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil.
Medipost Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipost Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medipost Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (Medipost Co) Business Description

Traded in Other Exchanges
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines